LCI Stock Overview
Manufactures and trades in soda ash, polyester, pharmaceuticals, chemicals and agri sciences, and animal health products.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Lucky Core Industries Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | PK₨1,015.99 |
| 52 Week High | PK₨1,116.70 |
| 52 Week Low | PK₨560.00 |
| Beta | 0.68 |
| 11 Month Change | 0.15% |
| 3 Month Change | 10.13% |
| 1 Year Change | 76.77% |
| 33 Year Change | 31.87% |
| 5 Year Change | 103.76% |
| Change since IPO | 25.99% |
Recent News & Updates
Recent updates
Shareholder Returns
| LCI | PK Chemicals | PK Market | |
|---|---|---|---|
| 7D | -0.4% | 5.2% | 0.8% |
| 1Y | 76.8% | 72.4% | 50.3% |
Return vs Industry: LCI exceeded the PK Chemicals industry which returned 72.4% over the past year.
Return vs Market: LCI exceeded the PK Market which returned 50.3% over the past year.
Price Volatility
| LCI volatility | |
|---|---|
| LCI Average Weekly Movement | 4.8% |
| Chemicals Industry Average Movement | 4.9% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in PK Market | 9.4% |
| 10% least volatile stocks in PK Market | 3.1% |
Stable Share Price: LCI has not had significant price volatility in the past 3 months compared to the PK market.
Volatility Over Time: LCI's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1944 | 2,232 | Asif Jooma | luckycore.com |
Lucky Core Industries Limited, together with its subsidiaries, manufactures and trades in soda ash, polyester, pharmaceuticals, chemicals and agri sciences, and animal health products. It offers light and dense ash, and refined sodium bicarbonate; and polyester staple fibers. The company also provides pharmaceutical products for gynecology, pediatrics, nutraceuticals, respiratory, pain and gastro, pulmonology, cardiology, cardio metabolic, oncology, central nervous system, and infectious diseases; and veterinary pharmaceuticals and nutraceuticals, such as antibiotics, anthelmintics, biologicals, antiprotozoals, nutritional supplements, and bovine genetics, as well as feed and farm solutions.
Lucky Core Industries Limited Fundamentals Summary
| LCI fundamental statistics | |
|---|---|
| Market cap | PK₨93.84b |
| Earnings (TTM) | PK₨11.15b |
| Revenue (TTM) | PK₨120.64b |
8.4x
P/E Ratio0.8x
P/S RatioIs LCI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LCI income statement (TTM) | |
|---|---|
| Revenue | PK₨120.64b |
| Cost of Revenue | PK₨93.70b |
| Gross Profit | PK₨26.94b |
| Other Expenses | PK₨15.79b |
| Earnings | PK₨11.15b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 120.73 |
| Gross Margin | 22.33% |
| Net Profit Margin | 9.24% |
| Debt/Equity Ratio | 33.6% |
How did LCI perform over the long term?
See historical performance and comparison